Mosquito Trap-N-Kill

Signal word

DDVP 10% Poison Warning

Hazard statements

Acute Toxicity, oral determined via Actue Toxic estimates to be Category 4 Acute Toxicity, dermal – LD50 >5050 mg/kg, Category 5 DDVP is poisonous if swallowed, inhaled or absorbed through skin and eyes. Rapidly absorbed through skin. Repeated inhalation or skin contact may without symptoms, progressively increases susceptibility to DDVP poisoning. Toxic to fish, birds and other wildlife. Do not contaminate bodies of water.

Principle Routes of Exposure

Ingestion, inhalation, and absorption through the eye or skin are all possible routes of entry for this active ingredient. Exposure by any of the routes may cause acute cholinesterase depression. Severe cholinesterase depression may be fatal. SIGNS OF ACUTE OVEREXPOSURE: Acute Cholinesterase depression may be evidenced by headache, nausea, vomiting, diarrhea, abdominal cramps, excessive seating salivation and tearing, constricted pupils, blurred vision, tightness in chest weakness, muscle twitching and confusion; in extreme cases, unconsciousness, convulsions, severe respiratory depression and death may occur. SIGNS OF CHRONIC OVEREXPOSURE: Repeated exposures to small doses of DDVP and other organophosphates may lower the cholinesterase to levels where the above symptoms of acute overexposure are observed. CARCINOGENICITY: EPA under its 199 proposed Guidelines for Carcinogen Risk Assessment has classified DDVP as having “suggestive evidence of carcinogenicity, but not sufficient to assess human carcinogenic potential”. IARC lists DDVP (Dichlorvos) as being possibly carcinogenic to humans (Group 2B). CARE SHOULD BE EXERCISED IN HANDLING DDVP AND ITS FORMULATIONS.